I would be interested to know what work is being done on T-cell
vaccination as it relates to multiple sclerosis.
I am referring to the work that Jingwu Zhang et al. published in 1994-5
(Cytotechnology: 16:181-187, 1994. and Lancet 1995; 346:807-08)
Does anyone know what the status of these studies are?
Is this clinical procedure being investigated at any centers other than
the center in Belgium?
Has there been any discussion concerning possible risks of T-cell
vaccination?
Replies appreciated,
Jeff Baclaski
